$JNJ $GILD $MRNA $NVAX $SNRE Johnson &amp; Johnson Chief Scientific Officer Dr. Paul Stoffels comments on CNBC; says company is ahead of schedule on development on COVID-19 vaccine  (149.41 +3.45)
Expects to start COVID-19 v... https://t.co/lNXgGIBhTH